Tools


Sitemap

Sitemap

VERSANT HIV-1 RNA 1.5 Assay (kPCR)

Highly Sensitive HIV Viral Load Assay for use on the VERSANT® kPCR Molecular System

  • Efficient and reproducible extraction, amplification, and detection of HIV-1 RNA
  • Up to 89 patient samples per run
  • Results in less than 6 hours
  • Excellent performance with quality extraction
  • Low limit of detection (LOD) with high accuracy
  • Good precision across a wide dynamic range
  • Compatible with a variety of subtypes and circulating recombinant forms
  • Primary-tube sampling supports a variety of tube types and sizes
  • Positive patient sample identification with bar-code ID for sample and results tracking
  • Up to 178 patient results per shift
  • 500 uL sample input volume
  • Enhanced sensitivity and specificity with BLACK HOLE QUENCHER**
  • Detects HIV-1 group M clades A–H, CRF, and group O
  • Targets highly conserved pol integrase gene with unique TAQMAN*** probes
  • Lower annealing temperature tolerates greater mismatch which leads to better subtype quantitation
  • Dual-primer and triple probe design to increase mismatch tolerance
  • Non-competitive internal control to monitor extraction and PCR efficiency
  • Amplicon contamination control with UNG

 

Assays currently available on the VERSANT kPCR Molecular System.

The VERSANT® HIV-1 RNA 1.5 Assay (kPCR) is IVDD, CE marked.

*Not for sale in the US. Not yet available for sale in all countries.

** BLACK HOLE QUENCHER is a trademark of Biosearch Technology.

*** TaqMan is a trademark of Roche Molecular Diagnostics, Inc.

The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

Did this information help you ?
Thank you for your response
We detected numbers and/or an '@' symbol in your comment. Are you trying to enter a phone number or email address so that we may contact you, please contact us via our email form instead.

Note: to get a direct personal response, please contact us via our email form.

Thank you